ORA - Oxford University Research Archive

1 - 5 of 5

1

Conference item

Safety and immunogenicity of the novel plasmodium falciparum blood-stage vaccine chad63-mva rh5 in a phase ia clinical trial

Payne, R, Silk, SE, Elias, SC, et al.
2017-03-05

2

Conference item

Safety and Immunogenicity of the malaria vaccine candidate R21 adjuvanted with matrix-m1 in West African adult volunteers, Burkina Faso

Tiono, AB, Ouedraogo, A, Coulibaly, SA, et al.
2017-11-01

3

Conference item

High level efficacy in humans of a next-generation plasmodium falciparum anti-sporozoite vaccine: R21 in Matrix-M (TM) adjuvant

Venkatraman, N, Bowyer, G, Edwards, NJ, et al.
2017-11-01

4

Conference item

The role of Regulatory T cells in the control of parasite growth and clinical outcomes following controlled human malaria infection in semi-immune Kenyan adults

Morter, RA, Nyabundi, D, Mwacharo, J, et al.
2018-10-01

5

Conference item

Durability of immune responses induced by three leading candidate ebola vaccine regimes; rVSV ZEBOV, ChAd3 EBO Z-MVA BN-Filo and AdHu26.ZEBOV-MVA BN Filo

Conference abstract
Ewer, KJ, Smith, C, Sarkar, E, et al.
2018-10-01

TO TOP